From October 1, the marginal prices for domestic drugs will change in Belarus
The Ministry of Health of Belarus has revised the maximum selling prices for medicines of domestic production. The new limits will be effective from October 1, 2026.

The Ministry of Healthcare of Belarus by Resolution No. 101 of September 17, 2026 revised the maximum selling prices for domestically produced medicines. The document is posted on the National Legal Internet Portal and comes into force from October 1, 2026.
New price limits are set for a wide range of drugs: antiparasitic, dermatological, anti-infectious, anticancer, immunomodulatory agents, as well as medicines for the respiratory system, digestive tract, metabolism, blood, nervous system and sense organs.
The list includes medicines of such enterprises as RUPP "Belmedpreparaty", JV LLC "PHARMLAND", CJSC "BELASEPTIKA", IPTUP "Reb-Pharma", OJSC "Borisov Plant of Medical Preparations", RUP "AKADEMPARM" and JSC "Ferain".
The document also regulates the cost of oxygen gaseous and liquid. The price of an oxygen cylinder now includes the costs of refueling, loading and unloading operations on the territory of the manufacturer and temporary use of the container by the consumer. The legal act was adopted pursuant to Decree No. 72 of February 25, 2011 on the issues of price regulation in the Republic of Belarus.
Photo: Pixabay



